Literature DB >> 3595102

ISMOD: an all-subsets regression program for generalized linear models. I. Statistical and computational background.

J F Lawless, K Singhal.   

Abstract

This paper describes a system written to carry out regression analyses under certain generalized linear models that are widely used in biomedical research. These include continuous response models such as the Weibull, log-logistic, log-normal and Cox proportional hazards models used in survival analysis, and also discrete Poisson, binomial and multinomial response regression models. The system fits models, generates residuals and other diagnostic output, and has an all-subsets regression feature. This paper describes the models implemented and gives statistical background; Part II describes the ISMOD system and presents examples of its application.

Entities:  

Mesh:

Year:  1987        PMID: 3595102     DOI: 10.1016/0169-2607(87)90022-8

Source DB:  PubMed          Journal:  Comput Methods Programs Biomed        ISSN: 0169-2607            Impact factor:   5.428


  5 in total

1.  Long-term changes in game species over a long period of transformation in the Iberian Mediterranean landscape.

Authors:  Miguel Delibes-Mateos; Miguel Angel Farfán; Jesús Olivero; Ana Luz Márquez; Juan Mario Vargas
Journal:  Environ Manage       Date:  2009-05-09       Impact factor: 3.266

2.  A comparison of all-subset Cox and accelerated failure time models with Cox step-wise regression for node-positive breast cancer.

Authors:  J A Chapman; M E Trudeau; K I Pritchard; C A Sawka; B G Mobbs; W M Hanna; H Kahn; D R McCready; L A Lickley
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

3.  Bayesian Framework to Augment Tumor Board Decision Making.

Authors:  Stefano Pasetto; Robert A Gatenby; Heiko Enderling
Journal:  JCO Clin Cancer Inform       Date:  2021-05

4.  Decline of COPD exacerbations in clinical trials over two decades - a systematic review and meta-regression.

Authors:  Stefan Andreas; Christian Röver; Judith Heinz; Sebastian Straube; Henrik Watz; Tim Friede
Journal:  Respir Res       Date:  2019-08-16

5.  Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas.

Authors:  C Bouchet; F Spyratos; P M Martin; K Hacène; A Gentile; J Oglobine
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.